Skip to main content

Abnormal Uterine Bleeding: Postmenopausal and Menopausal Transition

Kirsten R. Vitrikas, MD, Shreeya Raman, MD and Tamanna Noyon, DO Reviewed 05/2023
 


BASICS

DESCRIPTION

  • Menopausal transition (MT)

    • Commonly referred to as “perimenopause”

    • Begins with onset of cycle irregularity

    • Ends at 1 year from last menstruation

  • Menopause

    • Absence of menstruation for 1 ye...

DIAGNOSIS

HISTORY

  • Date of last menstruation

  • Bleeding patterns

    • Menses length/frequency

    • Volume of menstrual bleeding

    • Presence of midcycle bleeding

    • Postcoital bleeding

  • History of abnormal cervical lesions

  • Sexual...

TREATMENT

GENERAL MEASURES

  • Endometrial cancer, atypia, and hyperplasia must be ruled out prior to proceeding with treatment: In order to rule these out patient must have:

    • Negative cytology on endometria...

ONGOING CARE

FOLLOW-UP RECOMMENDATIONS

  • Routine gynecologic care such as cervical cancer screening

  • Should be followed by gynecologic oncology if indicated for premalignant or malignant diagnosis and trea...

REFERENCES

1
Committee on Practice Bulletins—Gynecology. Practice bulletin no. 136: management of abnormal uterine bleeding associated with ovulatory dysfunction. Obstet Gynecol...

ADDITIONAL READING

US Medical Eligibility Criteria (US MEC) for contraceptive use, 2016. https://www.cdc.gov/reproductivehealth/contraception/mmwr/mec/summary.html 

CODES

ICD10

  • N93.9 Abnormal uterine and vaginal bleeding, unspecified

  • N95.0 Postmenopausal bleeding

SNOMED

  • 44991000119100 Abnormal uterine bleeding

  • 266677000 Menopausal and postmenopausal disorders

  • 76742009 ...

CLINICAL PEARLS

  • Endometrial cancer must be reasonably ruled out in patients with AUB in MT or menopause.

  • Medical management should be first line for patients in MT, once endometrial cancer and hyperpla...

(8

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

×